All Section

All SMSNA News

A Possible Future Treatment Option for Male Hypogonadism

SMSNA Patients
Male hypogonadism is the medical term for low testosterone (the main male sex hormone). Historically, oral testosterone was not used to treat male hypogonadism due to the risk of hepatotoxicity, or damage to the liver. However, two oral testosterone formulations have now been approved by the FDA, and several other formulations seem to be on the horizon.
A Possible Future Treatment Option for Male Hypogonadism

SMSNA

SMSNA Patients

Attention: Restrictions on use of SMSNA content in third party applications, including artificial intelligence technologies, such as large language models and generative AI.

You are prohibited from using or uploading content you accessed through this website into external applications, bots, software, or websites, including those using artificial intelligence technologies and infrastructure, including deep learning, machine learning and large language models and generative AI.

Subscribe for our Newsletter!

Subscribe Now
Image

SMSNA

Foundation

Fellowship

For Patients